Eisai To Test Alzheimer's Drug On Young Down Syndrome Patients
This article was originally published in PharmAsia News
Executive Summary
Eisai said it plans to launch clinical trials in August to test its Aricept (donepezil) Alzheimer's disease drug for the additional use in aiding the social abilities of persons with Down syndrome.